American Health Ranitidine Tablet Recall [US]

American Health Ranitidine Tablet Recall [US]

Click to enlarge

US FlagUS/Silver Spring: American Health Packaging, a Columbus, Ohio establishment, recalls eleven (11) lots of Ranitidine Tablets, USP 150 mg, 100 count Unit Dose Blisters from the American marketplace due to suspected levels of N-Nitrosodimethylamine (“NDMA”), a probable Human Carcinogen, above the allowable limits established by the FDA and consequential risk of Cancer, all serious health hazards.

FDA: http://ht.ly/gFcQ30qnOVO

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/american-health-packaging-issues-voluntary-nationwide-recall-ranitidine-tablets-usp-150-mg-100-count

Additional information:
The US Food and Drug Administration (“FDA”) reports the following prescription drug products are subject to this recall:

Continue reading

Torrent Pharma Losartan Recall [US]

US FlagUS/Silver Spring: Torrent Pharma Losartan Recall [US]Torrent Pharmaceuticals Limited, an Ahmedabad, Gujarat establishment, expands its existing recalls from two (2) lots of Losartan Potassium Tablets USP to a total of ten (10) lots all unexpired batch/lots of due to suspected N-Nitrosodimethylamine (“NDMA”) contamination and consequential risks of Carcinogen damage and Cancer, all serious health hazards.

FDA: http://ht.ly/RmeV30ndMED

Direct link: https://www.fda.gov/Safety/Recalls/ucm629261.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Losartan Tablets are subject to this recall:

Continue reading

Torrent Pharma Valsartan Recall [US]

US FlagUS/Silver Spring: Torrent Pharma Valsartan Recall [US]Torrent Pharmaceuticals Limited, an Ahmedabad, Gujarat establishment, recalls all unexpired batch/lots of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets due to suspected N-Nitrosodimethylamine (“NDMA”) contamination and consequential risks of Carcinogen damage and Cancer, all serious health hazards.

FDA: http://ht.ly/Qhee30lylJS

Direct link: https://www.fda.gov/Safety/Recalls/ucm617821.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Valsartan Tablets are subject to this recall:

Continue reading

Camber Pharma Valsartan Recall [US]

US FlagUS/Silver Spring: Camber Pharmaceuticals LogoCamber Pharmaceuticals, Inc., a Piscataway, New Jersey, establishment, recalls all all unexpired batch/lots of Valsartan Tablets due to suspected N-Nitrosodimethylamine (“NDMA”) contamination and consequential risks of Carcinogen damage and Cancer, all serious health hazards.

FDA: http://ht.ly/klmd30ln4Uq

Direct link: https://www.fda.gov/Safety/Recalls/ucm616405.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Valsartan Tablets are subject to this recall:

Valsartan Tablets, USP, is a prescription medication used to treat high blood pressure and congestive heart failure and is packaged in 30-count bottles & 90-count bottles, all associated codes are provided in the table below with batch/lot designations and expiration dates.

Continue reading

%d bloggers like this: